Experimental cell therapy aims to tame severe, untreatable autoimmune diseases
Disease control
Ongoing
This early-stage study is testing a new cell therapy called CNTY-101 in people with severe autoimmune diseases like lupus, lupus nephritis, and scleroderma that have not improved with other treatments. The main goals are to find a safe dose and see if the therapy helps control th…
Phase: PHASE1 • Sponsor: Century Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC